Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention : Randomized Controlled Pilot Trial
©Faiz Khan, Nora Granville, Raja Malkani, Yash Chathampally. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 20.10.2020..
BACKGROUND: Systemic lupus erythematosus (SLE), a systemic autoimmune disease with no known cure, remains poorly understood and patients suffer from many gaps in care. Recent work has suggested that dietary and other lifestyle factors play an important role in triggering and propagating SLE in some susceptible individuals. However, the magnitude of influence of these triggers, how to identify pertinent triggers in individual patients, and whether removing these triggers confers clinical benefit is unknown.
OBJECTIVE: To demonstrate that a digital therapeutic intervention, utilizing a mobile app that allows self-tracking of dietary, environmental, and lifestyle triggers, paired with telehealth coaching, added to usual care, improves quality of life in patients with SLE compared with usual care alone.
METHODS: In this randomized controlled pilot study, adults with SLE were assigned to a 16-week digital therapeutic intervention plus usual care or usual care alone. Primary outcome measures were changes from baseline to 16 weeks on 3 validated health-related quality of life (HRQoL) tools: Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Brief Pain Inventory-Short Form (BPI-SF), and Lupus Quality of Life (LupusQoL).
RESULTS: A total of 50 patients were randomized (23 control, 27 intervention). In per-protocol analysis, the intervention group achieved significantly greater improvement than the control group in 9 of 11 domains: FACIT-F (34% absolute improvement for the intervention group vs -1% for the control group, P<.001), BPI-SF-Pain Interference (25% vs 0%, P=.02), LupusQoL-Planning (17% vs 0%, P=.004), LupusQoL-Pain (13% vs 0%, P=.004), LupusQoL-Emotional Health (21% vs 4%, P=.02), and LupusQoL-Fatigue (38% vs 13%, P<.001) were significant when controlling for multiple comparisons; BPI-SF-Pain Severity (13% vs -6%, P=.049), LupusQoL-Physical Health (17% vs 3%, P=.049), and LupusQoL-Burden to Others (33% vs 4%, P=.04) were significant at an unadjusted 5% significance level.
CONCLUSIONS: A digital therapeutic intervention that pairs self-tracking with telehealth coaching to identify and remove dietary, environmental, and lifestyle symptom triggers resulted in statistically significant, clinically meaningful improvements in HRQoL when added to usual care in patients with SLE.
TRIAL REGISTRATION: ClinicalTrials.gov NCT03426384; https://clinicaltrials.gov/ct2/show/NCT03426384.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Journal of medical Internet research - 22(2020), 10 vom: 20. Okt., Seite e23868 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khan, Faiz [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.02.2021 Date Revised 30.03.2024 published: Electronic ClinicalTrials.gov: NCT03426384 Citation Status MEDLINE |
|---|
| doi: |
10.2196/23868 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316483672 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316483672 | ||
| 003 | DE-627 | ||
| 005 | 20240330233124.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2196/23868 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1356.xml |
| 035 | |a (DE-627)NLM316483672 | ||
| 035 | |a (NLM)33079070 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khan, Faiz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention |b Randomized Controlled Pilot Trial |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.02.2021 | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT03426384 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a ©Faiz Khan, Nora Granville, Raja Malkani, Yash Chathampally. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 20.10.2020. | ||
| 520 | |a BACKGROUND: Systemic lupus erythematosus (SLE), a systemic autoimmune disease with no known cure, remains poorly understood and patients suffer from many gaps in care. Recent work has suggested that dietary and other lifestyle factors play an important role in triggering and propagating SLE in some susceptible individuals. However, the magnitude of influence of these triggers, how to identify pertinent triggers in individual patients, and whether removing these triggers confers clinical benefit is unknown | ||
| 520 | |a OBJECTIVE: To demonstrate that a digital therapeutic intervention, utilizing a mobile app that allows self-tracking of dietary, environmental, and lifestyle triggers, paired with telehealth coaching, added to usual care, improves quality of life in patients with SLE compared with usual care alone | ||
| 520 | |a METHODS: In this randomized controlled pilot study, adults with SLE were assigned to a 16-week digital therapeutic intervention plus usual care or usual care alone. Primary outcome measures were changes from baseline to 16 weeks on 3 validated health-related quality of life (HRQoL) tools: Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Brief Pain Inventory-Short Form (BPI-SF), and Lupus Quality of Life (LupusQoL) | ||
| 520 | |a RESULTS: A total of 50 patients were randomized (23 control, 27 intervention). In per-protocol analysis, the intervention group achieved significantly greater improvement than the control group in 9 of 11 domains: FACIT-F (34% absolute improvement for the intervention group vs -1% for the control group, P<.001), BPI-SF-Pain Interference (25% vs 0%, P=.02), LupusQoL-Planning (17% vs 0%, P=.004), LupusQoL-Pain (13% vs 0%, P=.004), LupusQoL-Emotional Health (21% vs 4%, P=.02), and LupusQoL-Fatigue (38% vs 13%, P<.001) were significant when controlling for multiple comparisons; BPI-SF-Pain Severity (13% vs -6%, P=.049), LupusQoL-Physical Health (17% vs 3%, P=.049), and LupusQoL-Burden to Others (33% vs 4%, P=.04) were significant at an unadjusted 5% significance level | ||
| 520 | |a CONCLUSIONS: A digital therapeutic intervention that pairs self-tracking with telehealth coaching to identify and remove dietary, environmental, and lifestyle symptom triggers resulted in statistically significant, clinically meaningful improvements in HRQoL when added to usual care in patients with SLE | ||
| 520 | |a TRIAL REGISTRATION: ClinicalTrials.gov NCT03426384; https://clinicaltrials.gov/ct2/show/NCT03426384 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a autoimmunity | |
| 650 | 4 | |a dietary intervention | |
| 650 | 4 | |a digital health | |
| 650 | 4 | |a digital therapeutic | |
| 650 | 4 | |a environmental influences on autoimmunity | |
| 650 | 4 | |a food as medicine | |
| 650 | 4 | |a health-related quality of life | |
| 650 | 4 | |a lifestyle medicine | |
| 650 | 4 | |a mobile health | |
| 650 | 4 | |a systemic lupus erythematosus | |
| 700 | 1 | |a Granville, Nora |e verfasserin |4 aut | |
| 700 | 1 | |a Malkani, Raja |e verfasserin |4 aut | |
| 700 | 1 | |a Chathampally, Yash |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical Internet research |d 1999 |g 22(2020), 10 vom: 20. Okt., Seite e23868 |w (DE-627)NLM116127104 |x 1438-8871 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2020 |g number:10 |g day:20 |g month:10 |g pages:e23868 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2196/23868 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2020 |e 10 |b 20 |c 10 |h e23868 | ||